fda glp-1 compounding crackdown news october 2025 Intensifies on FDA Ban on Compounded GLP-1
Description
A large new study found no link between semaglutide, the active ingredient in some GLP-1 drugs, and suicidal ideation.
The GLP-1 Market size was valued at USD 52.82 billion in 2025 and is expected to grow at a CAGR of 10.9% from 2026 to 2034.
IL-6 mirrored the time course of GLP-2
GLP1 drugs like Ozempic and Wegovy are transforming obesity and diabetes care
This treatment offers patients a flexible, daily pill option thats delivered directly to their door, at the best cash price.
She critiques a marketplace that often treats these powerful medications as consumer products rather than chronic disease therapies, noting the risks of obtaining prescriptions through brief online questionnaires without ongoing medical oversight
